Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $39,172 were sold by Boughton Soleil on Apr 01 ’24. At $15.65 per share, Boughton Soleil sold 2,503 shares. The insider’s holdings dropped to 166,866 shares worth approximately $2.45 million following the completion of this transaction.
Also, Dudum Andrew sold 50,361 shares, netting a total of over 823,055 in proceeds. Following the sale of shares at $16.34 each, the insider now holds 0 shares.
Before that, Okupe Oluyemi had sold 9,912 shares from its account. In a trade valued at $156,816, the Chief Financial Officer traded Hims & Hers Health Inc shares for $15.82 each. Upon closing the transaction, the insider’s holdings decreased to 9,912 shares, worth approximately $2.48 million.
As published in a research note from Imperial Capital on February 28, 2024, Hims & Hers Health Inc [HIMS] has been rated up from an In-line to an Outperform and the price target has been revised to $16. Analysts at Leerink Partners started covering the stock with ‘”a Market perform”‘ outlook in a report released in late February. As of December 07, 2023, Imperial Capital has initiated its “an In-line” rating for HIMS. Earlier on July 28, 2023, TD Cowen initiated its rating. Their recommendation was “an Outperform” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a drop of approximately -6.73%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 64.94%. Shares of the company reached a 52-week high of $17.16 on 03/25/24 and a 52-week low of $8.09 on 01/05/24. A 50-day SMA is recorded $12.37, while a 200-day SMA reached $8.80. Nevertheless, trading volume fell to 8.42 million shares from 7.35 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 14.00, which, if violated, would cause prices to drop to 13.33. In the upper region, resistance lies at 15.55. The next price resistance is at 16.42. RSI (Relative Strength Index) is 51.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.63, which suggests the price will decrease in the coming days. Percent R is at 80.52%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.71 million shares to 12.76 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 13.47 million shares. A decline of -5.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.71 of the overall float, the days-to-cover ratio (short ratio) decline to 1.71.
